Understand the cultural and socioeconomic influences that shape i...
Understand the cultural and socioeconomic influences that shape industry demand throughout Asia-Pacific, with local insight, market statistics and analysis ranging from strategic regional overview to in-depth coverage by country or city.
As is the case across consumer health in Taiwan, herbal/traditional varieties have continued to gain popularity in dermatologicals in 2023 amidst rising awareness of the potentially harmful side effects and contraindications of active pharmaceutical…
Dermatologicals is a saturated category in South Korea and has lost some of its growth momentum in terms of retail volume sales. A lack of new product development is one factor hampering stronger growth for some products, whilst another is increasing…
The social restrictions in Singapore at the start of the pandemic led to less time spent outside the home, and therefore less concern about looks. This contributed to volume and current value declines for hair loss treatments and medicated shampoos…
Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…
Dermatologicals saw an overall increase in demand in 2023, although performance varied somewhat by subcategory Nappy (diaper) rash treatments, for example, benefited from the return of consumers to more active lifestyles outside the home, which meant…
Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…
Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…
In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer…
The above-average, high single-digit current value growth expected in topical germicidals/antiseptics in 2023 is also driving growth within overall dermatologicals in India, as this is the largest category. This surge in sales has been driven by…
Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…
In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…
Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…
Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…
Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…
Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…
In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…
In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…
Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…
The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…
As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…